Patients are telling the truth — just not to you
September 21, 2026 | Data, Social Listening, clinical trials, patients
Patients are often most honest outside the clinic—revealing vital insights that can help clinical trial teams build trust, improve participation and collect better data.
There’s a familiar complaint in clinical research: patients don’t open up. They say they’re fine when they’re not. They under-report side effects. They nod through the consent conversation, and months later it’s clear they didn’t really follow it.
Spend an hour where patients talk to each other, though, and a different picture appears. They’re not guarded at all. They’re astonishingly honest — about what they fear, the side effects they hide, the days they can barely function. The truth isn’t missing. It’s just pointed somewhere other than the clinic.
That gap between what patients share with one another and what they tell the people providing their care is worth paying attention to. Because the things they don’t say out loud are usually the things a trial team most needs to hear.
What we miss in the room
It’s in patient communities where the quiet parts get said out loud.
On what it takes just to turn up, one person, deep into fertility treatment, wrote that they’d been going so long they had a favourite parking spot and no longer knew how to answer “how are you?” — “I am fine. I am functional.” The “fine” is doing a lot of work there.
On side effects, the honesty is sharper — and more uncomfortable. One cancer patient described hiding their symptoms “so I don’t have to wait another month for the next dose”.
Someone managing chronic pain put it plainly: they don’t tell the doctor about something that helps, “otherwise I’m an addict and not someone who needs help”. That isn’t non-compliance. It’s a calculation — that telling the truth might cost them their treatment.
Patients can also recognise when something isn’t right, sometimes before the clinical picture becomes clear. “The night of the procedure, I knew something was wrong,” one wrote — a concern later confirmed by the tests.
Some of this never gets said in the room. Some of it is said but not fully heard. All of it has value.
The silence isn’t soft — it shows up in your data
It’s tempting to file this under bedside manner. It isn’t. When patients don’t feel safe being honest, the consequences land exactly where a trial can least afford them.
Under-reported side effects create blind spots in safety data. The signals are there, they just aren’t always reaching you. Distress only becomes visible when someone quietly drops out. The burden of participation appears later as missed visits and withdrawals that seem to come from nowhere. A patient saying “I’m fine” isn’t a small social grace; it’s a missing data point. Honesty, in other words, isn’t a courtesy patients owe you. It’s the integrity of what you’re collecting.
Honesty is a design choice, not a personality trait
Patients aren’t withholding because they’re difficult or private. They’re withholding because, somewhere along the way, they learned that honesty has a cost — you lose the drug, you get dismissed, you become “the difficult one”, you worry people who already look worried.
So, the fix isn’t asking harder. It’s making honesty feel safer. That’s a design problem, and it runs through everything a participant touches: how a question is asked, how a reported side effect is met, whether the consent conversation invited questions or just collected a signature, whether the materials treat someone as an expert in their own condition or a beginner. Get those right and people tell you more, not because they suddenly trust strangers, but because the room made candour feel safer.
Start by listening where they’re already honest
If you want to understand what your participants aren’t saying, start where they’re already talking.
The version of the trial experience that rarely reaches the clinic already exists — in the open, in the communities where patients talk to one another. It will tell you which side effects people hide and why, what attending really costs, where the consent process loses them, and what they wish someone had asked. It’s the brief for every conversation you then design.
You don’t need to give people permission to speak openly in the abstract. Start by listening to what they’re already comfortable saying elsewhere. Then build the conditions where they’ll feel just as comfortable saying it to you.
Ready to talk?
Understanding what patients aren’t saying — and designing the materials and moments that help them say it — is what we do. If you want the real version of your participants’ experience, not just the version they feel able to share in clinic, let’s talk.
The patient voice here is drawn from public patient communities in our listening index, de-identified and lightly trimmed; medication names removed. It’s a self-selected, anonymous source — illustrative, not statistically representative — but it shows, in patients’ own words, the honest version they rarely say in clinic.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Key barriers to effective patient engagement in pharma, and how to fix them: Making engagement processes more patient friendly
In the first of this blog series, Patient Engagement Lead, Philippa Pristerà looks at making engagement processes more patient friendly
Cuttsy+Cuttsy awarded Gold accreditation by Investors in People
Healthcare communications agency, Cuttsy+Cuttsy, has been awarded ‘We invest in People, Gold’ from Investors in People.
Cuttsy+Cuttsy marks its 10th anniversary with the launch of Cuttsy Cares
Healthcare communications agency, Cuttsy+Cuttsy, has announced the launch of Cuttsy Cares, in celebration of its 10th anniversary. The agency’s charitable programme will deliver up to £10,000 to help improve the quality…
Caroline Benson and Colin Williams to Chair the PM Society from February 2020
For the first time both industry and agencies will be equally represented as the PM Society appoints a joint chair.
Clinical trials, Actually.
This Christmas, we’re thinking of the thousands of clinical trial volunteers across the UK, both patients and healthy participants. We have a lot to thank them for…
A patient view on the ABPI’s patient collaboration sourcebook
Last month, the ABPI released a much-in-demand document: The Working with Patients and Patient Organisations sourcebook.
The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years.
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation.
Clinical Trials Materials: Getting the Basics Right
For those unfamiliar with them, clinical trials can be rather bewildering. This presents problems when it comes to recruiting patients — how can we make sure they understand what they…
Cuttsy+Cuttsy named one of the Best Places to Work 2019 by Campaign
11 March 2019—Cuttsy+Cuttsy are honoured and extremely proud to be named one of the 50 Best Places to Work in 2019 by Campaign. The results were announced on 6th March…